Wealth Enhancement Advisory Services, LLC Abiomed Inc Transaction History

Wealth Enhancement Advisory Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$300.63 - $371.35 $1.14 Million - $1.41 Million	-3,786 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$310.19 - $376.2 $1.17 Million - $1.42 Million	3,786 New	3,786 $1.32 Million
Q2 2020 Aug 10, 2020	SELL	$141.4 - $257.09 $1.2 Million - $2.19 Million	-8,500 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$130.51 - $196.01 $1.11 Million - $1.67 Million	8,500 New	8,500 $1.4 Million
Q2 2019 Aug 02, 2019	SELL	$250.96 - $284.94 $788,014 - $894,711	-3,140 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$276.39 - $362.25 $45,051 - $59,046	-163 Reduced 4.93%	3,140 $823,000
Q4 2018 Feb 04, 2019	BUY	$281.08 - $444.25 $96,129 - $151,933	342 Added 11.55%	3,303 $1.1 Million
Q3 2018 Nov 02, 2018	SELL	$354.53 - $449.75 $53,179 - $67,462	-150 Reduced 4.82%	2,961 $1.04 Million
Q2 2018 Jul 30, 2018	BUY	$278.07 - $446.21 $865,075 - $1.39 Million	3,111 New	3,111 $1.28 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.